Zibo City First Hospital   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Zibo China (1948)

Organization Overview

First Clinical Trial
2016
NCT02728180
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Zibo First Hospital | Zibo Hospital of Traditional Chinese Medicine | Zibo municipal hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Infarction (Phase 4)

Fibrosis (Phase 4)

Hypertension, Portal (Phase 4)

Ischemia (Phase 4)

Leukemia (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Liver Cirrhosis (Phase 4)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 9